Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Shanghai Jiao Tong University School of Medicine Begins Clinical Trials of LE051 Exon 51 Skipping Therapy
Research
DMD Warrior
-
The purpose of LE051 study is to evaluate the safety, tolerability, and efficacy of LE051 intravenous therapy in DMD...
Translarna (Ataluren) Rejected by EMA: Marketing Authorization Not Renewed
Press Releases
DMD Warrior
-
In May 2024, PTC Therapeutics had been announced that the European Commission (EC) has decided not to adopt the...
DMD WarrioR’s Turkish Representative Shares His Views on Elevidys Gene Therapy: Is It Effective and Why Is It Expensive?
Editorials
DMD Warrior
-
The efficacy of Elevidys in treating Duchenne muscular dystrophy (DMD) has shown promising results in clinical studies, but are...
Fn14 Protein May Protect Muscle Stem Cells, Offering Promise for Development of Duchenne Treatments
Research
DMD Warrior
-
During Wave, Dyne, Regenxbio, Genethon and Others Plan to File FDA Application, Potential Safety Issues in Duchenne Worry Patients
Editorials
DMD Warrior
-
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks...
Press Releases
DMD Warrior
-
Chilean Health Ministry Says No Clinical Evidence of Improvement for Elevidys Gene Therapy
Editorials
DMD Warrior
-
Load more
